Market Place
Sourcing Support
Anixa Biosciences, Cleveland Clinic to Present Breast Cancer Data
28 Oct 2024 //
PR NEWSWIRE
Anixa Announces 2nd Dose Administered in Ovarian Cancer CAR-T Trial
15 Oct 2024 //
PR NEWSWIRE
Anixa Unveils Phase 2 Study Plan for Breast Cancer Vaccine
24 Sep 2024 //
PR NEWSWIRE
Anixa Biosciences Treats Sixth Patient In Ovarian Cancer CAR-T Clinical Trial
24 Jun 2024 //
PR NEWSWIRE
Anixa expands cancer vaccine collaboration with Cleveland Clinic
09 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
27 Nov 2023 //
PR NEWSWIRE
Anixa Announces Treatment of Second Patient in its Ovarian Cancer Trial
22 May 2023 //
PR NEWSWIRE
Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board
21 Feb 2023 //
PR NEWSWIRE
Anixa Biosciences to Present at Biotech Showcase 2023
19 Dec 2022 //
PRNEWSWIRE
Anixa begins Phase Ib trial of breast cancer vaccine
27 Oct 2022 //
CLINICALTRIALSARENA
Anixa Biosciences Announces on Ovarian Cancer CAR-T Therapy Trial at the (SITC)
10 Oct 2022 //
PRNEWSWIRE
Anixa Biosciences` Ovarian Cancer CAR-T Therapy to be Presented at Rivkin Center
12 Sep 2022 //
PRESS RELEASE
Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial
16 Aug 2022 //
CLINICALTRIALSARENA
Anixa Biosciences Treats First Patient in Ovarian Cancer CAR-T Clinical Trial
15 Aug 2022 //
PRNEWSWIRE
Anixa Announces Publication of Peer-Reviewed Journal Article in Vaccine Research
21 Jun 2022 //
PRNEWSWIRE
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at ASCO
28 Apr 2022 //
PRNEWSWIRE
Anixa Biosciences, MolGenie Find COVID Compounds Effective Against Omicron
08 Dec 2021 //
CONTRACTPHARMA
Anixa & MolGenie`s COVID-19 Compounds Expected to be Effective Against Omicron
07 Dec 2021 //
BIOSPACE
Anixa Begins Dosing of Investigational Vaccine in Preventative Breast Cancer
26 Oct 2021 //
PRNEWSWIRE
Anixa Biosciences’ CAR-T cancer treatment technology receives Chinese patent
07 Oct 2021 //
PHARMABIZ
Anixa Biosciences Announces Patent on its CAR-T Cancer Therapy Technology
06 Oct 2021 //
PRNEWSWIRE
Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance
30 Aug 2021 //
PRNEWSWIRE
Anixa Biosciences` Covid-19 Compounds to be Effective Against the Delta Variant
25 Aug 2021 //
PRNEWSWIRE
Anixa Biosciences places CAR-T therapy study on hold
19 Apr 2021 //
SEEKINGALPHA
Anixa and OntoChem to enter next stage of Covid-19 therapy development
06 Apr 2021 //
PHARMACEUTICAL
Anixa Biosciences Increases Previously Announced Bought Deal Offering
22 Mar 2021 //
PRNEWSWIRE
Anixa to Participate in M Vest LLC and Maxim Group LLC Conferences
08 Mar 2021 //
PRNEWSWIRE
Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy
04 Mar 2021 //
PRNEWSWIRE
Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy
03 Mar 2021 //
PRNEWSWIRE
Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates
17 Feb 2021 //
PRNEWSWIRE
Anixa initiates animal testing of Covid-19 therapeutic candidates
17 Feb 2021 //
PHARMACEUTICAL-TECHNOLOGY
Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates
16 Feb 2021 //
BIOSPACE
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Trial
22 Dec 2020 //
PRNEWSWIRE
Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency
14 Dec 2020 //
PRNEWSWIRE
Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds
13 Aug 2020 //
PRNEWSWIRE
Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
28 Jul 2020 //
PRNEWSWIRE
Anixa Biosciences to receive European patent for its novel CAR-T cancer
13 Jul 2020 //
PHARMABIZ
Anixa and OntoChem Announce Completion of Initial Screening Program
06 Jul 2020 //
PRNEWSWIRE
Anixa Biosciences and OntoChem Enter Next Stage of Development
05 Apr 2020 //
PRNEWSWIRE
Anixa Biosciences, OntoChem ink pact to proceed to next stage
05 Apr 2020 //
PHARMABIZ
